News February 2004
The University of Swansea is threatening to close its chemistry department.
Could a pH meter help to deal with terror threat?
Carbon nanotubes seem to have an endless stream of applications. The latest idea is to use them in brain implants, with a view to repairing areas of brain damage.
For many people who have to take prescription drugs to treat chronic conditions.
UK food chemist has found a way to explode the deadly food-poisoning bacteria.
Scottish researchers find new arsenic compound.
US researchers claim to have developed robust and reusable organic light-emitting diodes (OLEDs).
We all know that eating plenty of green vegetables may help to prevent cancer.
French researchers identify structure of key TB enzyme.
Researchers from BioMarin Pharmaceutical, a US biotechnology company, have developed a new technique which they claim could help to reduce patients' immune responses to protein-bas...
Researchers from Swiss pharmaceutical company Roche have discovered a class of chemical compound that could form the basis of a new approach to tackling cancer.
Roche has been forced to suspend development of one of its new HIV drugs because of formulation problems.
Does the answer to fuel cell research lie with H2 clathrates?
SkyePharma, the UK drug delivery company, has revealed that it intends to reorganise its R & D operations, resulting in job losses.
US pharma giant Pfizer is set to acquire a US biotechnology company created by a group of scientists that worked on the discovery and development of its cardiovascular drug Lipitor...
Following its acquisition last year of fellow UK biotechnology company KS Biomedix.
Biomolecular engineers develop chip to monitor living cells in real time.
The search is on for more sensitive materials to create images with.
The historical origins of dragon's blood - the deep red resins obtained from Dracaena plants - can now be used to identify accurately resins of unknown origin.
Novel enzyme mimic could be used to help treat inflammatory diseases.
Tiny molecular machines that can build themselves are the futuristic-sounding goal of supramolecular chemists.
Mimicry of the cleverest kind is under way in the labs of Ally Aukauloo at the UniversitÚ Paris-Sud in France.
Drugs based on cyclam, a simple cyclic molecule, show promise in the war against HIV by blocking the path of the virus into cells.
The usefulness of a recently developed reaction, the intramolecular Michael addition, can be improved in order to show enantioselectivity.
Researchers at Liverpool University have shown that enzymes that cleave DNA are still effective when the DNA is bound to spherical gold nanoparticles.
Enzymes that initiate a flip-flop action in membrane lipids have been designed by Bradley Smith and his research group at the University of Notre Dame.
Modifying gold nanoparticles with zinc porphyrins leads to enhanced anion recognition properties claims a team of inorganic chemists from the University of Oxford.
Single molecule manipulation of the twist in the DNA double helix can answer a host of tricky questions in molecular biology.
Plants can adapt their metabolism to make sugars during the hours of darkness.
Aromatic rings have been created with the twisted topology of a M÷bius band.